Knight Therapeutics | GUD - Market Capitalization

Stock Price
7.68
Daily Change
0.23 3.09%
Monthly
23.87%
Yearly
34.97%
Q2 Forecast
7.26

Knight Therapeutics reported CAD768.89M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 1B 55.93M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025